Jeffrey M Leiden insider trades: Odyssey Therapeutics (ODTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
58 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | ODTX | ↑ Buy | 5,000 | $20.00 | $100K | Direct | May 11, 2026 (3d) |
| Dec 3, 2025 | VRTX | ↓ Sell | 63,781 | $449.20 | $28.7M | Direct | Dec 5, 2025 (2d) |
| Nov 14, 2025 | VRTX | ↓ Sell | 73,292 | $440.60 | $32.3M | Direct | Nov 17, 2025 (3d) |
| Aug 30, 2024 | VRTX | ↓ Sell | 3,784 | $499.00 | $1.9M | Direct | Sep 4, 2024 (5d) |
| Feb 15, 2024 | VRTX | ↓ Sell | 9,011 | $419.10 | $3.8M | Direct | Feb 16, 2024 (1d) |
| Feb 13, 2024 | VRTX | ↓ Sell | 3,393 | $419.42 | $1.4M | Direct | Feb 14, 2024 (1d) |
| Jan 8, 2024 | VRTX | ↓ Sell | 6,648 | $419.07 | $2.8M | Direct | Jan 10, 2024 (2d) |
| Dec 13, 2023 | VRTX | ↓ Sell | 13,354 | $399.42 | $5.3M | Direct | Dec 15, 2023 (2d) |
| Oct 16, 2023 | VRTX | ↓ Sell | 12,962 | $374.00 | $4.8M | Direct | Oct 18, 2023 (2d) |
| May 8, 2023 | VRTX | ↓ Sell | 2,004 | $349.25 | $700K | Direct | May 9, 2023 (1d) |
| May 3, 2023 | VRTX | ↓ Sell | 10,958 | $349.98 | $3.8M | Direct | May 4, 2023 (1d) |
| Jul 25, 2022 | VRTX | ↓ Sell | 132,079 | $281.38 | $37.2M | Direct | Jul 27, 2022 (2d) |
| Apr 13, 2022 | VRTX | ↓ Sell | 15,789 | $289.04 | $4.6M | Direct | Apr 14, 2022 (1d) |
| Jun 30, 2020 | VRTX | ↓ Sell | 32,792 | $286.15 | $9.4M | Direct | Jul 2, 2020 (2d) |
| May 12, 2020 | VRTX | ↓ Sell | 94,370 | $283.47 | $26.8M | Direct | May 14, 2020 (2d) |
| May 7, 2020 | VRTX | ↓ Sell | 94,369 | $269.78 | $25.5M | Direct | May 8, 2020 (1d) |
| May 5, 2020 | VRTX | ↓ Sell | 94,372 | $269.94 | $25.5M | Direct | May 7, 2020 (2d) |
| Feb 25, 2020 | VRTX | ↓ Sell | 10,550 | $233.46 | $2.5M | Direct | Feb 26, 2020 (1d) |
| Feb 18, 2020 | VRTX | ↓ Sell | 11,685 | $243.52 | $2.8M | Direct | Feb 19, 2020 (1d) |
| Feb 11, 2020 | VRTX | ↓ Sell | 47,523 | $246.09 | $11.7M | Direct | Feb 12, 2020 (1d) |
| Nov 19, 2019 | VRTX | ↓ Sell | 96,534 | $210.91 | $20.4M | Direct | Nov 21, 2019 (2d) |
| Nov 18, 2019 | VRTX | ↓ Sell | 9,434 | $210.00 | $2.0M | Direct | Nov 19, 2019 (1d) |
| Nov 1, 2019 | VRTX | ↓ Sell | 105,701 | $200.02 | $21.1M | Direct | Nov 4, 2019 (3d) |
| Oct 22, 2019 | VRTX | ↓ Sell | 107,831 | $190.00 | $20.5M | Direct | Oct 24, 2019 (2d) |
| Jun 18, 2019 | VRTX | ↓ Sell | 56,030 | $175.39 | $9.8M | Direct | Jun 20, 2019 (2d) |
| May 24, 2019 | VRTX | ↓ Sell | 113,432 | $175.10 | $19.9M | Direct | May 28, 2019 (4d) |
| May 6, 2019 | VRTX | ↓ Sell | 30,758 | $175.01 | $5.4M | Direct | May 8, 2019 (2d) |
| May 6, 2019 | VRTX | ↓ Sell | 2,300 | $175.02 | $403K | Direct | May 8, 2019 (2d) |
| May 1, 2019 | VRTX | ↓ Sell | 10,480 | $175.08 | $1.8M | Direct | May 3, 2019 (2d) |
| Feb 19, 2019 | VRTX | ↓ Sell | 20,997 | $186.98 | $3.9M | Direct | Feb 21, 2019 (2d) |
| Feb 11, 2019 | VRTX | ↓ Sell | 111,431 | $180.24 | $20.1M | Direct | Feb 13, 2019 (2d) |
| Feb 4, 2019 | VRTX | ↓ Sell | 32,250 | $186.35 | $6.0M | Direct | Feb 6, 2019 (2d) |
| Jun 22, 2018 | VRTX | ↓ Sell | 140,211 | $160.00 | $22.4M | Direct | Jun 26, 2018 (4d) |
| May 29, 2018 | DGX | ↓ Sell | 1,644 | $105.61 | $174K | Direct | May 30, 2018 (1d) |
| Feb 12, 2018 | VRTX | ↓ Sell | 23,905 | $150.83 | $3.6M | Direct | Feb 14, 2018 (2d) |
| Jan 16, 2018 | VRTX | ↓ Sell | 99,563 | $156.99 | $15.6M | Direct | Jan 17, 2018 (1d) |
| Dec 11, 2017 | VRTX | ↓ Sell | 125,000 | $141.35 | $17.7M | Direct | Dec 11, 2017 (0d) |
| Aug 4, 2017 | DGX | ↓ Sell | 296 | $106.66 | $32K | Direct | Aug 8, 2017 (4d) |
| Jul 31, 2017 | VRTX | ↓ Sell | 11,063 | $152.81 | $1.7M | Direct | Aug 2, 2017 (2d) |
| Jul 27, 2017 | DGX | ↓ Sell | 1,304 | $108.73 | $142K | Direct | Jul 31, 2017 (4d) |
| Jul 21, 2017 | VRTX | ↓ Sell | 216,624 | $160.96 | $34.9M | Direct | Jul 21, 2017 (0d) |
| Jun 2, 2017 | VRTX | ↓ Sell | 147,101 | $129.50 | $19.0M | Direct | Jun 5, 2017 (3d) |
| Apr 28, 2017 | VRTX | ↓ Sell | 157,200 | $119.50 | $18.8M | Direct | Apr 28, 2017 (0d) |
| Feb 13, 2017 | VRTX | ↓ Sell | 23,904 | $87.68 | $2.1M | Direct | Feb 15, 2017 (2d) |
| Aug 3, 2016 | DGX | ↓ Sell | 6,345 | $85.62 | $543K | Direct | Aug 4, 2016 (1d) |
| Feb 3, 2016 | VRTX | ↓ Sell | 9,834 | $90.82 | $893K | Direct | Feb 4, 2016 (1d) |
| Nov 18, 2015 | VRTX | ↓ Sell | 16,125 | $130.00 | $2.1M | Direct | Nov 20, 2015 (2d) |
| Oct 30, 2015 | VRTX | ↓ Sell | 16,125 | $125.56 | $2.0M | Direct | Nov 3, 2015 (4d) |
| Feb 18, 2015 | VRTX | ↓ Sell | 32,250 | $112.89 | $3.6M | Direct | Feb 20, 2015 (2d) |
| Dec 15, 2014 | VRTX | ↓ Sell | 50,017 | $114.97 | $5.8M | Direct | Dec 16, 2014 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ODTX insiders
Open-market trades in the last 12 months
About Jeffrey M Leiden's insider trades
Jeffrey M Leiden is an insider at Odyssey Therapeutics (ODTX). Since Feb 17, 2006, Jeffrey has reported 3 open-market purchases worth $200K and 55 sales worth $545.0M on SEC Form 4. In the last 12 months: 1 buy ($100K) and 2 sales ($60.9M).
Their filings also include grants and awards (40 filings), option exercises (26 filings), shares withheld for taxes (25 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ODTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.